GOVX GeoVax Labs: ערך חשבונאי למניה

GeoVax Labs, Inc. (GOVX) is developing innovative vaccines for oncology and viruses while awaiting test results and new government contracts. The change in BVPS on the GURU.Markets chart confirms this foundation, where 0.24 indicates the current level of asset backing. Stability is guaranteed by reliable global supply chains for biocomponents and an absence of geopolitical risks due to the humanitarian status of the company's activities.

The intellectual capital of GeoVax Labs, Inc. (GOVX), concentrated in immunotherapy patents and vaccine development, forms the material basis for the future monetization of medical discoveries. The dynamics of the book value per share indicator reflect the ratio of net assets to the number of shares, allowing investors to assess the real value of the company's assets and determine the stability of equity over a long-term horizon.